| Ordinary Shares | Additional Paid-in | (Accumulated Deficit)/ Retained | Total Shareholder’s | |||||||||||||||||
| Shares | Amount | Capital | earnings | Equity | ||||||||||||||||
| Balance as of January 30, 2024 (inception) | - | $ | - | $ | - | $ | - | $ | - | |||||||||||
| Founder shares issued to Sponsor(1) | 1,437,500 | 144 | 24,856 | - | 25,000 | |||||||||||||||
| Net loss | - | - | - | (2,091) | (2,091) | |||||||||||||||
| Balance as of March 31, 2024 | 1,437,500 | $ | 144 | $ | 24,856 | $ | (2,091) | $ | 22,909 | |||||||||||
| Net loss | - | - | - | (2,637) | (2,637) | |||||||||||||||
| Balance as of June 30, 2024 | 1,437,500 | $ | 144 | $ | 24,856 | $ | (4,728) | $ | 20,272 | |||||||||||
| Proceeds allocated to Public Rights | - | - | 5,010,612 | - | 5,010,612 | |||||||||||||||
| Sale of private placement shares | 299,000 | 30 | 2,989,970 | - | 2,990,000 | |||||||||||||||
| Issuance of representative shares | 57,500 | 5 | 522,014 | - | 522,019 | |||||||||||||||
| Underwriters’ discount | - | - | (1,384,519) | - | (1,384,519) | |||||||||||||||
| Other offering expenses | - | - | (460,994) | - | (460,994) | |||||||||||||||
| Accretion of ordinary share subject to redemption value | - | - | (164,960) | - | (164,960) | |||||||||||||||
| Net income | - | - | - | 141,906 | 141,906 | |||||||||||||||
| Balance as of September 30, 2024 | 1,794,000 | $ | 179 | $ | 6,536,979 | $ | 137,178 | $ | 6,674,336 | |||||||||||
| Schedule of fair value on a recurring basis | |||||||
| Description | Level | September 30, 2024 | |||||
| (Unaudited) | |||||||
| Assets: | |||||||
| Marketable securities held in Trust Account | 1 | $ | 57,935,279 | ||||
| For the Three Months Ended September 30, 2024 | For the Period From January 30, 2024 (Inception) Through September 30, 2024 | |||||||
| Formation and operating costs | $ | 918 | $ | 5,646 | ||||
| Administrative fee | 5,667 | 5,667 | ||||||
| Total operating expenses | 6,585 | 11,313 | ||||||
| Loss from Operations | (6,585) | (11,313) | ||||||
| Other income: | ||||||||
| Interest income | 712 | 712 | ||||||
| Income earned on marketable securities held in Trust Account | 147,779 | 147,779 | ||||||
| Total other income | 148,491 | 148,491 | ||||||
| Net Income | $ | 141,906 | $ | 137,178 | ||||
| Basic and diluted weighted average ordinary shares outstanding, redeemable ordinary shares | 1,074,176 | 400,615 | ||||||
| Basic and diluted net income per ordinary share, redeemable ordinary shares | $ | 0.14 | $ | 0.40 | ||||
| Basic and diluted weighted average ordinary shares outstanding, non-redeemable ordinary shares | 1,351,626 | 1,287,902 | ||||||
| Basic and diluted net loss per ordinary share, non-redeemable ordinary shares | $ | (0.01) | $ | (0.02) | ||||
| For the Period From January 30, 2024 (Inception) Through | ||||
| September 30, 2024 | ||||
| Cash Flows from Operating Activities: | ||||
| Net income | $ | 137,178 | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Income earned on marketable securities held in Trust Account | (147,779) | |||
| Changes in operating assets and liabilities: | ||||
| Prepaid expenses | (9,769) | |||
| Due to related parties | 5,667 | |||
| Net Cash Used in Operating Activities | (14,703) | |||
| Cash Flows from Investing Activities: | ||||
| Purchase of marketable securities held in Trust Account | (57,787,500) | |||
| Net Cash Used in Investing Activities | (57,787,500) | |||
| Cash Flows from Financing Activities: | ||||
| Proceeds from issuance of ordinary shares to Sponsor | 25,000 | |||
| Proceeds from issuance of promissory note to related party | 375,000 | |||
| Repayment of promissory note to related party | (375,000) | |||
| Proceeds from sale of public units through public offerings, net of underwriters’ discount | 56,637,500 | |||
| Proceeds from ordinary shares issued in private placement | 2,990,000 | |||
| Payment of offering costs | (385,994) | |||
| Net Cash Provided by Financing Activities | 59,266,506 | |||
| Net Change in Cash | 1,464,303 | |||
| Cash, Beginning of Period | - | |||
| Cash, End of Period | $ | 1,464,303 | ||
| Supplemental Disclosure of Non-cash Investing and Financing Activities: | ||||
| Offering costs included in accrued offering costs | 75,000 | |||
| Representative shares issued and charged to offering costs | 522,019 | |||
| Accretion of ordinary shares subject to redemption value | 164,960 | |||
| Schedule of Basic and Diluted Net Loss Per Share | ||||||||||||||||
| For the Three Months Ended | For the Period From January 30, 2024 (Inception) Through | |||||||||||||||
| September 30, 2024 | September 30, 2024 | |||||||||||||||
| Redeemable Ordinary Share | Non-Redeemable Ordinary Share | Redeemable Ordinary Share | Non-Redeemable Ordinary Share | |||||||||||||
| (Unaudited) | (Unaudited) | |||||||||||||||
| Numerators: | ||||||||||||||||
| Allocation of net loss | $ | (10,209) | $ | (12,845) | $ | (6,592) | $ | (21,190) | ||||||||
| Accretion of initial measurement of ordinary shares subject to redemption value | 164,960 | - | 164,960 | - | ||||||||||||
| Allocation of net income (loss) | $ | 154,751 | $ | (12,845) | $ | 158,368 | $ | (21,190) | ||||||||
| Denominators: | ||||||||||||||||
| Weighted-average ordinary shares outstanding | 1,074,176 | 1,351,626 | 400,615 | 1,287,902 | ||||||||||||
| Basic and diluted net income (loss) per share | $ | 0.14 | $ | (0.01) | $ | 0.40 | $ | (0.02) | ||||||||
